Pneumothorax during lenvatinib plus pembrolizumab for recurrent endometrial cancer: A case report
Objective: Pneumothorax is a rare adverse event in cancer treatment. Lenvatinib, a multi-kinase inhibitor with antiangiogenic activity, may cause organ perforation. We present a case of pneumothorax during lenvatinib plus pembrolizumab (LP) therapy for endometrial cancer. Case report: A 63-year-old...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2025-09-01
|
| Schriftenreihe: | Taiwanese Journal of Obstetrics & Gynecology |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S1028455925001895 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|